Literature DB >> 19643188

Callosal atrophy in mild cognitive impairment and Alzheimer's disease: different effects in different stages.

Margherita Di Paola1, Eileen Luders, Fulvia Di Iulio, Andrea Cherubini, Domenico Passafiume, Paul M Thompson, Carlo Caltagirone, Arthur W Toga, Gianfranco Spalletta.   

Abstract

Alzheimer's Disease (AD) is a neurodegenerative disorder that mainly affects grey matter (GM). Nevertheless, a number of investigations have documented white matter (WM) pathology associated with AD. The corpus callosum (CC) is the largest WM fiber bundle in the human brain. It has been shown to be susceptible to atrophy in AD mainly as a correlate of Wallerian degeneration of commissural nerve fibers of the neocortex. The aim of this study was to investigate which callosal regions are affected and whether callosal degeneration is associated with the stage of the disease. For this purpose, we analyzed high-resolution MRI data of patients with amnesic mild cognitive impairment (MCI) (n=20), mild AD (n=20), severe AD (n=10), and of healthy controls (n=20). Callosal morphology was investigated applying two different structural techniques: mesh-based geometrical modeling methods and whole-brain voxel-based analyses. Our findings indicate significant reductions in severe AD patients compared to healthy controls in anterior (genu and anterior body) and posterior (splenium) sections. In contrast, differences between healthy controls and mild AD patients or amnesic MCI patients were less pronounced and did not survive corrections for multiple comparisons. When correlating anterior and posterior WM density of the CC with GM density of the cortex in the severe AD group, we detected significant positive relationships between posterior sections of the CC and the cortex. We conclude that callosal atrophy is present predominantly in the latest stage of AD, where two mechanisms might contribute to WM alterations in severe AD: the Wallerian degeneration in posterior subregions and the myelin breakdown process in anterior subregions.

Entities:  

Mesh:

Year:  2009        PMID: 19643188      PMCID: PMC2764791          DOI: 10.1016/j.neuroimage.2009.07.050

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  89 in total

Review 1.  Diffusion tensor imaging of normal and injured developing human brain - a technical review.

Authors:  J Neil; J Miller; P Mukherjee; P S Hüppi
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

2.  Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.

Authors:  S J Teipel; W Bayer; G E Alexander; A L W Bokde; Y Zebuhr; D Teichberg; F Müller-Spahn; M B Schapiro; H-J Möller; S I Rapoport; H Hampel
Journal:  Neurobiol Aging       Date:  2003 Jan-Feb       Impact factor: 4.673

3.  Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T.

Authors:  R Deichmann; C Schwarzbauer; R Turner
Journal:  Neuroimage       Date:  2004-02       Impact factor: 6.556

4.  Progression of corpus callosum atrophy in Alzheimer disease.

Authors:  Stefan J Teipel; Wolfram Bayer; Gene E Alexander; York Zebuhr; Diane Teichberg; Luka Kulic; Marc B Schapiro; Hans-Jürgen Möller; Stanley I Rapoport; Harald Hampel
Journal:  Arch Neurol       Date:  2002-02

5.  Hand and sex differences in the isthmus and genu of the human corpus callosum. A postmortem morphological study.

Authors:  S F Witelson
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

6.  Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study.

Authors:  Lena Bronge; Nenad Bogdanovic; Lars-Olof Wahlund
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

7.  Apparent atypical callosal dysgenesis: analysis of MR findings in six cases and their relationship to holoprosencephaly.

Authors:  A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  1990 Mar-Apr       Impact factor: 3.825

8.  Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia.

Authors:  Hidekazu Tomimoto; Jin-Xi Lin; Akinori Matsuo; Masafumi Ihara; Ryo Ohtani; Masunari Shibata; Yukio Miki; Hiroshi Shibasaki
Journal:  J Neurol       Date:  2004-04       Impact factor: 4.849

9.  Dynamics of gray matter loss in Alzheimer's disease.

Authors:  Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 10.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

View more
  41 in total

1.  Application of fused lasso logistic regression to the study of corpus callosum thickness in early Alzheimer's disease.

Authors:  Sang H Lee; Donghyeon Yu; Alvin H Bachman; Johan Lim; Babak A Ardekani
Journal:  J Neurosci Methods       Date:  2013-10-09       Impact factor: 2.390

2.  Sexual dimorphism in the human corpus callosum: an MRI study using the OASIS brain database.

Authors:  Babak A Ardekani; Khadija Figarsky; John J Sidtis
Journal:  Cereb Cortex       Date:  2012-08-13       Impact factor: 5.357

3.  Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.

Authors:  Sahar Elahi; Alvin H Bachman; Sang Han Lee; John J Sidtis; Babak A Ardekani
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Frontal-executive and corticolimbic structural brain circuitry in older people with remitted depression, mild cognitive impairment, Alzheimer's dementia, and normal cognition.

Authors:  Benoit H Mulsant; Aristotle N Voineskos; Neda Rashidi-Ranjbar; Tarek K Rajji; Sanjeev Kumar; Nathan Herrmann; Linda Mah; Alastair J Flint; Corinne E Fischer; Meryl A Butters; Bruce G Pollock; Erin W Dickie; John A E Anderson
Journal:  Neuropsychopharmacology       Date:  2020-05-18       Impact factor: 7.853

5.  Progression of corpus callosum atrophy in early stage of Alzheimer's disease: MRI based study.

Authors:  Minwei Zhu; Wenpeng Gao; Xudong Wang; Chen Shi; Zhiguo Lin
Journal:  Acad Radiol       Date:  2012-02-18       Impact factor: 3.173

6.  Disruption of thalamic connectivity in Alzheimer's disease: a diffusion tensor imaging study.

Authors:  Qing-Yong Zhu; Si-Wei Bi; Xiu-Ting Yao; Zhi-Yan Ni; Ying Li; Bo-Yu Chen; Guo-Guang Fan; Xiu-Li Shang
Journal:  Metab Brain Dis       Date:  2015-07-04       Impact factor: 3.584

7.  Callosal thickness reductions relate to facial dysmorphology in fetal alcohol spectrum disorders.

Authors:  Yaling Yang; Owen R Phillips; Eric Kan; Kathleen K Sulik; Sarah N Mattson; Edward P Riley; Kenneth L Jones; Colleen M Adnams; Philip A May; Mary J O'Connor; Katherine L Narr; Elizabeth R Sowell
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

8.  Corpus callosum shape changes in early Alzheimer's disease: an MRI study using the OASIS brain database.

Authors:  Babak A Ardekani; Alvin H Bachman; Khadija Figarsky; John J Sidtis
Journal:  Brain Struct Funct       Date:  2013-01-16       Impact factor: 3.270

9.  MRI characteristics and scoring in HDLS due to CSF1R gene mutations.

Authors:  Christina Sundal; Jay A Van Gerpen; Alexandra M Nicholson; Christian Wider; Elizabeth A Shuster; Jan Aasly; Salvatore Spina; Bernardino Ghetti; Sigrun Roeber; James Garbern; Anne Borjesson-Hanson; Alex Tselis; Russell H Swerdlow; Bradley B Miller; Shinsuke Fujioka; Michael G Heckman; Ryan J Uitti; Keith A Josephs; Matt Baker; Oluf Andersen; Rosa Rademakers; Dennis W Dickson; Daniel Broderick; Zbigniew K Wszolek
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

10.  Callosal degeneration topographically correlated with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease dementia.

Authors:  Pei-Ning Wang; Kun-Hsien Chou; Ni-Jung Chang; Ker-Neng Lin; Wei-Ta Chen; Gong-Yau Lan; Ching-Po Lin; Jiing-Feng Lirng
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.